Neisseria meningitidis possède un PTS incomplet. Constitué des composants générales EI et HPr et de deux EIIAs (EIIANtr et EIIAMan), ce système ne permet pas le transport des sucres chez cette bactérie. Cependant, nous avons confirmé que la cascade de phosphorylation (EI HPr EIIANtr) est fonctionnelle et que HPr est aussi phosphorylée sur sa Ser-46 par une HprK/P.Dans l’objectif d’étudier l’effet de HPr sur la virulence de N. meningitidis, nous avons construit un mutant ΔptsH chez N. meningitidis 2C4-3. Le mutant ΔptsH a montré une faible survie chez la souris, une faible production de la capsule, une meilleure adhérence aux cellules épithéliales et un niveau élevé de cellules apoptotiques, par rapport à la souche sauvage. HPr semble intervenir dans la virulence de N. meningitidis en interagissant avec la protéine CrgA. L’interaction HPr/CrgA est plus forte quand HPr est phosphorylée sur sa Ser-46 par HprK/P.N. meningitidis utilise le glucose et le maltose comme seuls sucres. Nous avons identifié une perméase à glucose (GlcP) et une perméase à maltose (MalY), responsables du transport de ces sucres. Une perméase putative à gluconate (GntP) a été également identifiée chez N. meningitidis 2C4-3. Cette perméase n’assure pas le transport du gluconate, dans les conditions testées. La délétion de gntP chez N. meningitidis 2C4-3 induit une meilleure croissance sur glucose et une bonne survie du mutant ΔgntP chez la souris, par rapport à la souche sauvage. La fonction réelle de la perméase GntP chez N. meningitidis reste inconnue et suscite des études ultérieures. / Neisseria meningitidis has an incomplete PTS composed of general proteins EI and HPr and two EIIAs (EIIANtr and EIIAMan). This system does not allow the transport of sugars in this bacterium. However, we confirmed that the phosphorylation cascade (EI HPr EIIANtr) is functional and HPr is also phosphorylated at its Ser-46 by an HprK/P.In order to study the effect of HPr on meningococcal virulence, we constructed a ΔptsH mutant in N. meningitidis 2C4-3. Compared to the wild-type strain, the ΔptsH mutant showed poor survival in mice, low production of capsule, better adherence to epithelial cells and high levels of apoptotic cells. HPr appears to be involved in the virulence of N. meningitidis by interacting with CrgA protein. The HPr/CrgA interaction is stronger when HPr is phosphorylated at its Ser-46 by HprK/P.N. meningitidis uses glucose and maltose as the only sugars. We identified permeases for glucose (GlcP) and maltose (MalY), which catalyze the uptake of these sugars.A putative gluconate permease (GntP) has also been identified in N. meningitidis 2C4-3. Under the conditions tested, this permease did not catalyze the transport of gluconate. Compared to the wild-type strain, deletion of gntP in N. meningitidis 2C4-3 induced faster growth on glucose and a better survival of the mutant in mice. To underst and the function of the GntP permease in N. meningitidis further studies will have to be carried out.

O presente trabalho teve o objetivo de verificar a influência da inoculação de ingredientes intra ovo aos 18 dias de incubação de ovos oriundos de matrizes jovens e de pesos distintos. Ovos oriundos de matrizes com 30 semanas de idade foram separados em ovos leves e pesados, sendo incubados na mesma máquina incubadora. Aos 18 dias de incubação, no momento da transferência para o nascedouro, os ovos foram inoculados com soluções de Maltose, Polivitamínico, Zinco-Glicina, Glutamina, Mistura de todos os produtos descritos anteriormente e Cloreto de Sódio (controle). Como via de inoculação, as soluções foram utilizadas como diluentes da vacina de Marek efetuada intra-ovo aos 18 dias de incubação. Após o nascimento, 2460 pintinhos machos foram enviados para o aviário experimental onde foram divididos em 60 boxes em um delineamento inteiramente casualizado em esquema fatorial 2x6 (2 pesos e 6 soluções) totalizando 12 tratamentos com 5 repetições de 40 aves. Foram sacrificadas uma ave por repetição aos 00, 07 e 21 dias de idade para pesagem do saco da gema, intestino e fígado. Amostras de duodeno, jejuno e íleo foram enviadas para histologia para determinação de profundidade de criptas e altura de vilosidades. Amostras de sangue foram coletadas e enviadas para laboratório para determinação de nível de anticorpos contra reovírus e bronquite aviária. Os animais e a ração fornecida foram pesados semanalmente (07, 14, 21, 28, 35 e 42 dias) para determinação do peso, consumo e conversão alimentar. Aos 43 dias de idade 3 aves por repetição foram pesadas e sacrificadas para determinação do peso e rendimento de carcaça, peito com osso e pele e perna com osso e pele. Animais oriundos de ovos mais pesados obtiveram uma maior eclosão, peso ao nascimento e peso de fígado e intestino aos 00 dias. O peso aos 42 dias foi superior em aves oriundas de ovos pesados, produzindo uma carcaça e peito mais pesado, porém sem diferença de rendimento. Não houve diferença de conversão aos 42 dias de idade. Viabilidade de animais oriundos de ovos pesados foi superior de 00 a 07, 14 a 21 e 21 a 28 dias de idade, mas não afetou a viabilidade final. Peso do ovo não interferiu com o nível de anticorpos. As inoculações de soluções aos 18 dias de incubação obtiveram resultados variáveis dependendo do produto utilizado, tendo maior influência sobre altura de vilosidades e profundidade de criptas e sobre a produção de anticorpos. Não afetaram, entretanto, os parâmetros zootécnicos (ganho de peso, consumo de ração, conversão alimentar e viabilidade). A inoculação de produtos intra-ovo já é uma técnica possível de ser utilizada na avicultura industrial, entretanto, novos estudos devem ser ainda desenvolvidos no intuito de definir o melhor produto ou composto de produtos a ser utilizado / This trial had the objective to verify the influence of the in-ovo inoculation of ingredients at 18th day of incubation of eggs from different weights. Eggs from a broiler breeder flock with 30 weeks of age were separated in light and heavy eggs and were incubated in the same machine. At the 18th day of incubation, when the eggs were been transferred, they were inoculated with solutions of Maltose, Vitamins, Zinc-Glicine, Glutamine, mixture of all the ingredients and sodium chloride (control). The solutions were inoculated as Marek\'s vaccine diluter. After the eclosion, 2460 male chicks were send to the experimental house were they were divided on 60 boxes at a completely random design and a factorial 2x6 (two egg weigths and six solutions) design, summing 12 treatments with 5 repetitions of 40 chicks. One chick per repetition was sacrificed at 00, 07 and 21 days of age to weigth the yolk sac, intestine and liver. Samples of duodenum, jejunum and ileum were sent to histology to determinate villus high and cripts deep. Blood sample of the same birds were collected and sent to the laboratory to determinate anti body levels against reovirus and avian bronquitis. Animals and feed were weighted every week to determine the animal weight gain, feed consumption and feed conversion. At 43 days of age, 3 birds per repetition were weighted and sacrificed to determinate the carcass, breast and leg weight and yield. Animals from heavy eggs had a higher born weight, eclosion and liver and intestine weight at 00 days. At 42 days of age, birds from heavier eggs had a higher weight producing a heavier carcass and breast, but without yield variation. There was no difference on feed conversion at 42 days. Liveability of birds from heavier eggs were higher form 00 to 07, 14 to 21 and 21 to 28 days of age, but it didn\'t interfere the total livibility. Egg weight didn\'t interfere on the anti body level. The solutions inoculated at 18th day of incubation had variable results depending on the product utilized, influencing the villus height and cripts deep and anti body production. However, the solutions inoculation doesn\'t interfere on zoothecnical parameters as weight gain, feed consumption, feed conversion and livability. The in-ovo inoculation is a technique possible to be used on broiler production, however, new studies have to be done searching from the best product or ingredient to be used

Le gène de l’entérotoxine thermostable b (estB) d’Escherichia coli a été fusionné au gène de la protéine liant le maltose (malE) dans le vecteur pMAL-p via PCR. Par la suite, deux constructions plasmidiques ont été realisées à partir de ce nouveau vecteur, nommé pMAL-STb. Dans un premier temps, un marqueur hexahistidine (His6) a été ajouté entre malE et estB, et dans un deuxième temps, un marqueur décahistidine (His10) a été placé en amont de malE. La séquence signal de la protéine liant le maltose (MBP) dirige l’exportation de la protéine de fusion du cytoplasme vers le périplasme, où l’entérotoxine STb acquière sa conformation active. MBP est également reconnue pour améliorer le rendement et la solubilité de la protéine passagère tandis que le marqueur histidine, connu comme étant le meilleur marqueur d’affinité pour la purification protéique, facilite sa purification jusqu’à homogénéité. De plus, les gènes fusionnés sont sous le contrôle du promoteur tac (Ptac), un promoteur fort et inductible. Suite à l’induction par l’IPTG, la souche recombinante exprime une protéine d’environ 48 kDa, qui est facilement identifiable par électrophorèse à partir du surnageant obtenu via choc osmotique. Une séquence encodant un site de clivage spécifique au facteur Xa est présente dans le plasmide afin de séparer les marqueurs MBP et histidine de STb. Le clivage de la protéine de fusion avec le facteur Xa libère MBP (42 kDa) attachée au marqueur histidine et un polypeptide de 5.2 kDa, correspondant au poids moléculaire de STb mature. Avec cette méthode, nous visons à obtenir une méthode plus efficace pour la production et la purification de STb. / The heat-stable enterotoxin b gene (estB) of Escherichia coli was fused to the gene for maltose-binding protein (malE) into the pMAL-p vector using PCR. Afterward, two plasmid constructs were realized from this new vector, named pMAL-STb. Firstly, a hexahistidine tag (His6) was added between malE and estB and secondly, a decahistidine tag (His10) was placed upstream of malE. The signal sequence of maltose-binding protein (MBP) directs the export of the fusion protein from the cytoplasm to the periplasm, where the enterotoxin STb acquires its active conformation. MBP is also known to improve the yield and solubility of the passenger protein while the histidine tag, viewed as the best affinity tag for protein purification, facilitates its purification to homogeneity. Furthermore, the fused genes are controlled by the tac promoter (Ptac), a strong inducible promoter. Following IPTG induction, the recombinant strain expressed a protein of approximately 48 kDa, which is easily identified from osmotic shock fluid following electrophoresis. A sequence encoding a factor Xa cleavage site is present in the plasmid to separate MBP and histidine tags from STb. The cleavage of the fusion protein with factor Xa generates the maltose-binding protein (42 kDa) attached to the histidine tag and a polypeptide of 5.2 kDa, corresponding to the molecular mass of mature STb. With this method, we aim at obtaining a more efficient way to produce and purify STb.

Das multiple Myelom ist eine seltene maligne Knochenerkrankung bei insbesondere älteren Menschen. Dabei vermehren sich im Knochenmark in hohem Maße unkontrolliert entartete Plasmazellen. Diese Myelomzellen unterdrücken einerseits die Bildung von normalen Plasmazellen, andererseits wird das Gleichgewicht zwischen Knochenaufbau und –abbau empfindlich gestört, woraus eine erhöhte Knochenresorption resultiert. Neben den bisher angewandten Chemo- und Strahlentherapien gewinnen innovative Medikamente, wie Proteasominhibitoren und Bisphosphonate, in der Therapie an Bedeutung. Diese Medikamente reduzieren das Myelomzellwachstum und wirken hemmend auf den Knochenabbau. Durch das Auffüllen von durch Resorptionsprozesse geschädigten Knochendefekten mit wirkstoffbeladenen Calciumphosphatzementen (CPC) wird nicht nur der Knochen stabilisiert, sondern im Vergleich zur herkömmlichen oralen oder intravenösen Medikamentenverabreichung eine gezielte Freisetzung des Wirkstoffes direkt am Wirkort in wesentlich reduzierten Dosen ermöglicht. Durch die Kombination des Knochenzementes mit anderen effizienten Drug-Delivery-Systemen (DDS), wie z. B. Polymeren, kann eine optimale Anpassung der Wirkstofffreisetzung ermöglicht werden. Insbesondere haben sich bereits dendritische Polymere aufgrund ihrer globularen Struktur und Vielzahl an peripheren Funktionalitäten als besonders geeignete Wirkstoffträgersysteme herausgestellt. Bei der Anwendung im physiologischen System spielt insbesondere die Biokompatibilität dieser polymeren DDS eine entscheidende Rolle. Durch Modifizierung der peripheren Gruppen mit biokompatiblen Einheiten, wie Oligosacchariden oder Aminosäuren, kann die physiologische Verträglichkeit signifikant erhöht werden. Für die Behandlung des multiplen Myeloms am Knochen sollte in dieser Arbeit ein geeignetes dendritisches DDS auf Basis von hochverzweigtem Polyethylenimin (PEI) synthetisiert und charakterisiert werden. Das DDS sollte dabei verschiedene Anforderungen, wie eine hohe Wasserlöslichkeit und Biokompatibilität, erfüllen. Weiterhin sollten die mechanischen Eigenschaften des CPC nicht negativ beeinflusst werden und der Wirkstoff sollte effektiv vom DDS aufgenommen und kontrolliert aus dem generierten Komposit (Wirkstoff/DDS/CPC) freigesetzt werden. In der sogenannten N-Carboxyanhydrid (NCA)-Polymerisation wurden am PEI(5) (5 ≙ Mw 5 kDa) benzylgeschützte Polyglutaminsäure bzw. Polyasparaginsäureketten aufgepfropft. Durch hydrolytische Abspaltung der Schutzgruppen an den PBLG-Ketten von PEI(5)-PBLG-346 und PEI(5)-PBLA-346 erfolgte die Generierung der wasserlöslichen DDS PEI(5)-PGlu-346 und PEI(5)-PAsp-346. Die Charakterisierung der synthetisierten Kern-Schale-Architekturen PEI(5)-PBLG-346, PEI(5)-PBLA-346, PEI(5)-PGlu-346 und PEI(5)-PAsp-346 zeigte, dass nur wenige lange Polyaminosäureketten an wenigen primären und sekundären Aminogruppen des PEI(5) aufgebaut wurden. Aufgrund der noch freien primären und sekundären Aminogruppen am PEI(5) und den peripheren Aminogruppen an den Polyaminosäureketten wurden durch die Anbindung von Maltose- bzw. Laktoseeinheiten Kern-Schale-Architekturen mit einer binären Doppelschalenstrukturen erzeugt. Im Gegensatz zu reiner Polyglutaminsäure zeigten die mit Glutaminsäure modifizierten Polymerstrukturen PEI(5)-PGlu-346 und PEI(5)-PGlu-346-Mal interessante strukturelle Eigenschaften in wässriger Umgebung. Aufgrund des pH-abhängigen Ladungszustandes resultiert bei reinen Polyglutaminsäureketten normalerweise der typische Helix-Coil-Übergang. Dabei findet eine Konformationsumwandlung der α-helikalen Struktur zur ungeordneten Sekundärstruktur statt. Im Falle der PEI(5)-PGlu-346- und PEI(5) PGlu-346-Mal-Copolymere wurde jedoch keine α-helikale Konformation bei niedrigem pH-Wert nachgewiesen. Die PGlu-Ketten der wasserlöslichen Kern-Schale-Architekturen bildeten sowohl im sauren, als auch im basischen pH-Wertbereich eine ungeordnete Sekundärstruktur aus. Zusätzlich konnte nachgewiesen werden, dass die Kern-Schale-Architekturen in Abhängigkeit vom pH-Wert als isolierte Makromoleküle bzw. Aggregate mit unterschiedlich lang gestreckten Peptidketten vorliegen. Die Ursache dafür sind nicht-kovalente, intra- und intermolekular wirkende Kräfte. Zur Beurteilung der Kern-Schale-Architekturen als geeignete DDS wurde die Komplexierung des Proteasominhibitors Bortezomib (BZM) in die reinen Copolymere PEI(5)-PGlu-346, PEI(5)-PGlu-346-Mal und PEI(25)-Mal B (25 ≙ Mw 25 kDa, ohne Polyglutaminsäureketten) sowie deren Polyelektrolytkomplexe untersucht. Dabei wurden Copolymer/BZM- bzw. PEK/BZM-Komplexe in verschiedenen Verhältnissen hergestellt und die Komplexierungskapazität durch zeitabhängige Ultrafiltration UV/Vis-spektroskopisch ermittelt. Im Vergleich zu den glutaminsäuremodifizierten Copolymeren wurde durch PEI(25)-Mal B etwa doppelt so viel Wirkstoff in verschiedenen wässrigen Systemen aufgenommen. Der Grund dafür ist der größere PEI-Kern und die dementsprechend höhere Anzahl an peripheren Aminogruppen mit gebundenen Maltoseeinheiten. Die PEK zeigten im Vergleich zu den Copolymeren keine Verbesserung der Komplexierungskapazität. Um eine effektive Wirkstofffreisetzung für eine dosierte Langzeittherapie aus dem Kompositmaterial zu erhalten, ist eine stark verzögerte Freisetzung des Copolymers bzw. PEK selbst aus dem CPC notwendig. In Abhängigkeit von der Konzentration wurde für PEI(25)-Mal B eine geringere Freisetzung aus dem Copolymer/CPC- und PEK/CPC ermittelt. Aufgrund der nanoskaligen Dimension der polymeren Strukturen wird die Diffusion durch das offene CPC-Porensystem erschwert. Für die PEI(5)-PGlu-346, PEI(5)-PGlu-346-Mal und die zugehörigen PEK wurde hingegen keine messbare Freisetzung aus dem CPC nachgewiesen. Die Glutaminsäureeinheiten können Calciumionen komplexieren und beeinflussen dadurch die Keimbildung und das Wachstum der CaP-Phase. Die Copolymerstrukturen werden somit in den CPC integriert und können nur durch Abbau des schwerlöslichen Zementes freigesetzt werden. Bei den Untersuchungen der BZM-Freisetzung aus den BZM/Copolymer/CPC- und BZM/PEK/CPC-Kompositen kristallisierte sich BZM/PEI(5)-PGlu-346-Mal/CPC als effektivstes DDS heraus. Im Vergleich zum reinen BZM in CPC wurde nach 24 h nur etwa die Hälfte des Wirkstoffes aus dem Komposit freigesetzt. Weiterhin steigerte sich die Freisetzungsrate über den gesamten Zeitraum von 14 Tagen auf nur etwa 60 %. Aus dem BZM/CPC-Komposit wurden nach 14 Tagen mehr als 75 % BZM freigesetzt. In Kooperation mit der Arbeitsgruppe von Prof. Michael Gelinsky vom Zentrum für Translationale Knochen-, Gelenk- und Weichgewebeforschung (TU Dresden) wurde keine signifikante Änderung der Druckfestigkeit des CPC durch die Integration der glutaminsäuremodifizierten Copolymere festgestellt. Weiterhin wurde in in vitro-Untersuchungen mit osteogen stimulierten humanen mesenchymalen Stammzellen (hMSC) kein entscheidender Einfluss der in dieser Arbeit hergestellten PEI(5)-PGlu-346- und PEI(5)-PGlu-346-Mal-Copolymere auf die Proliferation der Zellen beobachtet. Zudem war bei beiden Copolymeren eine osteogene Differenzierung der hMSC zu knochenbildenden Osteoblasten nachweisbar, wobei PEI(5)-PGlu-346-Mal die Entwicklung der Stammzellen zu knochenbildenden Zellen sogar zu fördern scheint. Durch die Kombination von hochverzweigtem PEI mit Polyglutaminsäure und Maltose wurde in dieser Arbeit ein innovatives DDS für die kontrollierte und effektiv verzögerte Freisetzung von BZM aus CPC erzeugt, welches die einleitend erwähnten Anforderungen erfüllt. Das Copolymersystem weist eine hohe Biokompatibilität auf, ohne die mechanischen Eigenschaften des CPC zu verändern. Diese Arbeit hat daher einen entscheidenden Beitrag im Bereich der Wirkstofffreisetzung aus festen Materialien geliefert und bildet die Grundlage für zukünftige polymere DDS in CPC.

Avec pour problématique une importante variabilité des lots de production vaccinale contre la diphtérie, une analyse intégrative du métabolisme central, du fer et du transcriptome de Corynebacterium diphtheriae, cultivé en conditions les plus proches de la culture industrielle, ont permis d’élargir les connaissances sur le comportement de la bactérie en conditions de production industrielle, et plus particulièrement sur l’existence de corrélations entre activité métabolique et virulence. L'analyse du métabolisme central et la comparaison de l'expression des gènes de C. diphtheriae, ont permis de mettre en évidence l'importance du maltose dans l'établissement de la virulence. Ce sucre, largement présent dans notre alimentation, est ainsi rencontré par la bactérie lors de son processus de colonisation de l'hôte. La consommation du maltose lors de la phase stationnaire, coïncident avec la production de la toxine, semble ainsi liée aux réactions de maintenance et à la production de métabolites secondaires plutôt qu'à la croissance. Plusieurs gènes liés à la capture et au catabolisme du maltose sont liés à la production de la toxine diphtérique. Cependant, les mécanismes de régulation sont complexes, impliquant plusieurs régulateurs. Une étude sur les besoins en fer de la bactérie et les liens avec la pathogénicité a été réalisée. En effet, le gène de la toxine diphtérique est régulé par DtxR, répresseur activé par Fe2+. Elle a permis d'évaluer la capacité de stockage en fer de la bactérie et la limite de concentration intracellulaire pour obtenir une production de toxine. Un effort a été apporté afin de visualiser les ferritines synthétisées par la bactérie par la technique NanoSIMS. Enfin, l'analyse de l'expression des gènes de C.diphtheriae cultivé en condition de limitation en fer et supplémentée en fer a apporté une quantité d'informations sur les liens entre métabolisme central et du fer, virulence et stress oxydatif. Cette démarche a été mise à profit afin de proposer à l'industriel des pistes d'optimisations du procédé et d’améliorations de la productivité en toxine diphtérique. Via l’ajustement de certains paramètres physico-chimiques (visant l'oxygénation et une meilleure métabolisation du maltose), il est possible d'obtenir un gain de production significatif (titre final en toxine multiplié par 2,5). La productivité spécifique en toxine peut être également multipliée par 2,2 par une astucieuse étape de dilution et recyclage de la biomasse en fin de culture / Faced with an important variability in production yields of vaccines against diphtheria, a dynamic systemic approach, including central and iron metabolism and transcriptome analysis, led to an improved knowledge of Corynebacterium diphtheriae physiology, notably as regards the connection of central metabolism and virulence. Gene expression analysis coupled to metabolic characterization enabled a correlation between maltose consumption and virulence to be established. Because of the typical human diet, maltose is present in the human oropharynx where it may serve as a key nutrient source for C. diphtheriae. Maltose consumption during stationary phase, coupled with toxin production, seems to be linked to maintenance and secondary metabolites rather than growth. Several genes, including uptake and catabolism of maltose, are related to diphtheria toxin production. However, mechanisms of regulation are complex and may involve several transcriptional regulators. Bacterial iron requirements and its relation to pathogenicity were considered. Indeed, diphtheria toxin gene is regulated by Fe2+ activated DtxR. These studies revealed that C. diphtheriae is able to store an important quantity of intracellular iron within ferritin-like proteins visualized by NanoSIMS microscopy and the definition of an intracellular threshold concentration provoking expression of toxin production. Finally, genome-wide gene expression analysis of C.diphtheriae in iron starvation and iron excess conditions provided information on relations between central and iron metabolism, virulence establishment and oxidative stress. The resulting knowledge was exploited to suggest process optimization strategies to enhance toxin production, currently being assessed by the industrial partner. Adjusting some key physico-chemical parameters (targeting oxygenation and better maltose metabolization) enabled significant gains in toxin production (2.5 fold increase). Specific productivity could be increased by 2.2 thanks to a novel biomass dilution and recycling step at the end of the culture

A captação de maltose em bactérias é feita por um sistema transportador do tipo ABC composto por uma proteína ligadora de substrato (MalE), duas proteínas transmembrana e uma ATPase. No presente trabalho descrevemos a clonagem, expressão e análise bioquímica e estrutural da proteína MalE da bactéria fitopatogênica Xanthomonas axonopodis pv citri (Xac) O gene malE de Xac foi clonado em vetor de expressão pET28a, a proteína recombinante foi expressa em Escherichia coli e purificada por cromatografia de afinidade ao níquel. Amostras da proteína solúvel foram analisadas quanto à estrutura secundária, interação com possíveis ligantes, estabilidade frente a diferentes condições físico-químicas. Ensaios de cristalização possibilitaram a obtenção de cristais em diferentes condições, um deles apresentou grupo espacial P6122, mas não foi possível resolver a estrutura. Com base nas estruturas conhecidas de ortólogos de MalE, geramos um modelo estrutural para a proteína de Xac e foram feitas análises quanto à interação com trealose e maltose. Modelos estruturais dos componentes transmembrana (LacF e LacG) e ATPase (UgpC) do sistema transportador de maltose de Xac também foram gerados. Os resultados representam uma contribuição importante para o conhecimento sobre a fisiologia e sistemas de transporte de Xac. / Maltose uptake in bacteria is mediated by an ABC transporter comprising a substrate binding protein (MalE), two transmembrane proteins, and one ATPase. In the present study, we describe the cloning, expression and biochemical as well as structural analyses of the MalE protein of the phytopagen Xanthomonas axonopodis pv citri (Xac). The malE gene of Xac was cloned in the pET28a expression vector, the recombinant protein was expressed in Escherichia coli and, subsequently, purified by nickel affinity chromatography. Samples of soluble protein were analyzed regarding secondary structure, interaction with putative ligants and stability under different physico-chemical conditions. Crystallization trials were carried out under different conditions, one particular condition yielded crystal with a P6122space group, but the structure was not solved. Based on known ortholog structures, a structural model for Xac MalE was obtained allowing interaction with modeled threhalose and maltose. Structural models the transmembrane (LacF and LacG) and ATPase (UgpC) components were also obtained. The present results represent an important contribution to the knowledge of the physiology and transporter systems found in Xac.

A proteína de ligação a maltose (MBP) é amplamente conhecida na literatura como um marcador para métodos de purificação de afinidade e é freqüentemente fusionada a proteínas relevantes para melhorar seu rendimento, facilitando sua purificação e aumentando sua estabilidade e solubilidade. Por outro lado, foi relatado que o nitrogênio piridínico não quaternizado do filme eletropolimerizado com N-(3-pirrol-1-ilpropil)-4,4\'-bipiridínio (PPB) desempenhou um papel importante na imobilização da proteína de ligação da maltose (MBP). Neste trabalho relatamos a modificação do eletrodo de carbono vítreo (CV) pela redução eletroquímica do derivado de arildiazônio piridínico gerado in situ e seu uso na imobilização da proteína MBP fusionada à galectina-1 (MBP-Gal-1). Resultados de voltametria cíclica mostraram formação de monocamadas com carga positiva sobre CV e que o nitrogênio não quaternizado da piridina estava disponível após a modificação. Os resultados da Espectroscopia de Capacitância Eletroquímica (ECC) indicaram que o domínio do MBP foi importante para a interação do eletrodo modificado. O tempo de imobilização e a concentração de proteína fusionada também foram relevantes para a cinética e os resultados sugeriram uma saturação em 40 minutos de interação, utilizando 5 mol L-1 de MBP-Gal-1. Experimentos de detecção de lactose indicaram que a atividade da galectina-1 foi preservada após a imobilização. A reação click realizada para promover a inclusão da maltose na superfície desse eletrodo modificado gerou resultados significativamente melhores quando comparados aos do eletrodo sem a maltose ligada em sua superfície: a proteína fusionada MBP-Gal-1 demonstrou um aumento de 62% na imobilização. Também foram observados aumentos na sensibilidade para detecção de lactose (72%) e na especificidade de interação com este mesmo carboidrato (77%) / Maltose Binding Protein (MBP) is widely known in the literature as a tag for affinity purification methods and it is often fused to relevant proteins to improve its yield, facilitating its purification and enhance its stability and solubility. On the other hand, it was reported that the nonquaternized pyridine nitrogen from N-(3-pyrrol-1-ylpropyl)-4,4-bipyridinium electropolymerized film (PPB) played an important role for the immobilization of maltose binding protein (MBP). In this work we reported the glassy carbon electrode (GCE) modification by electrochemical reduction of pyridinium diazonium salt derivative generated in situ and its use on MBP fused to Galectin-1 protein (MBP-Gal-1) immobilization. Cyclic voltammetry results showed a positively charged monolayer formation onto GCE and that nonquaternized pyridine nitrogen was available after modification. Electrochemical Capacitance Spectroscopy (ECS) results indicated that the MBP domain was important for the modified electrode interaction. Immobilization time and the fused protein concentration were also relevant to the kinetics and the results suggested a monolayer saturation in 40 minutes of interaction, using 5 mol L-1 MBP-Gal-1. The click reaction performed to promote the inclusion of maltose on the surface of this modified electrode generated better results when compared to those of the electrode without maltose bounded to its surface: the MBP-Gal-1 fused protein demonstrated a 62% increase in immobilization. Increases in sensitivity for lactose detection (72%) and specificity of interaction with this same carbohydrate (77%) were also observed

ABC (ATP-binding-cassette)-Transporter katalysieren den ATP-abhängigen Transport diverser niedermolekularer Substanzen durch die biologische Zellmembran. Ihr Vorkommen erstreckt sich auf alle drei Domänen des Lebens. Der Maltose Transporter von E.coli gehört zu dieser Superfamilie der ABC-Transporter. Die Kristallstrukturen des Transporters MalFGK2 wurden kürzlich gelöst für dessen inaktiven Zustand als auch für dessen katalytischen Zwischenzustand. Um den Transportmechanismus besser verstehen zu können, müssen die Kristallstrukturen des Transporters und seiner Komponenten unter physiologischen Bedingungen genau geprüft werden, um den daraus katalytischen Mechanismus zu bewerten. Im rahmen der Dissertation konnte mittels Lösungs-NMR kann gezeigt werden, dass die periplasmatische Schleife P2 von MalF eine unabhängige Faltung aufweist und eine wohl definierte Tertiärstruktur einnimmt, die vergleichbar ist mit der im Kristall vorliegenden Konformation. MalF-P2 interagiert unabhängig von der Transmembranregion von MalF und MalG mit dem Maltose-Bindeprotein in An- und Abwesenheit des Substrats mit einem KD im mikromolaren Bereich. NMR Untersuchungen zu den an der Interaktion beteiligten Aminosäuren stehen in Einklang mit den Kristallstrukturdaten. Die Analyse residualer dipolarer Kopplungen (RDC) zeigt, dass die Konformation der zwei individuellen Domänen von MalF-P2 in Abwesenheit von MalE erhalten bleibt und der im Kristall ähnelt. Die Zugabe von MalE induziert eine Änderung der relativen Orientierung der zwei Domänen von MalF-P2 um so dem räumlichen Anspruch des Liganden gerecht zu werden. Besonders betroffen hiervon ist die Domäne 2 von MalF-P2, deren Konformation abweicht von der in der Kristallstruktur. Die Struktur der Domäne 1 dagegen bleibt konserviert, während sich lediglich ihre relative Orientierung zu Domäne 2 ändert. MD Simulationen des MalF-P2-MalE-Komplexes deuten auf eine stark dynamische Interaktion von MalF-P2 mit der MalE Bindungsregion hin. NMR CPMG Kinetikstudien weisen auf die Bildung eines ungewöhnlichen Knicks in alhpa-Helix alpha2 während der Assoziation hin. Diese konformelle Änderung der alpha-Helix findet auf einer Zeitskala von Millisekunden statt, was im Einklang mit der Austauschrate der Komplexbildung ist. / ABC (ATP-binding-cassette)-transporters catalyze the ATP-dependent transport of diverse solutes across the cellular membrane. They are present in all three kingdoms of life. The E.coli maltose transporter belongs to the ATP binding cassette (ABC) transporter superfamily. Recently, the crystal structures of the full transporter MalFGK2 in its resting and a catalytic intermediate state was solved. At the present state of research, it is of particular interest to scrutinize the X-ray structures of the transporter and its components under physiological conditions as well as to evaluate their implications for the catalytic mechanism. In the context of the PhD thesis, it could be shown using solution-state NMR that the periplasmic loop P2 of MalF folds independently in solution and adopts a well-defined tertiary structure, which is similar to the one found in the crystal structure. MalF-P2 interacts with the maltose binding protein, independent of the transmembrane region of MalF and MalG, with a KD in the µM range, in the presence and absence of substrate. NMR studies showed good agreement of the residues interacting in solution to those identified in the X-ray structure. Analysis of residual dipolar coupling (RDC) experiments shows that the conformation of the two individual domains of MalF-P2 is preserved in the absence of MalE, and resembles the conformation in the X-ray structure. Upon titration of MalE to MalF-P2, the two domains of MalF-P2 change their relative orientation in order to accommodate the ligand. In particular, a conformational change of domain 2 of MalF-P2 is induced, which is distinct to the conformation found in the X-ray structure. Domain 1 retains its structure but changes its relative orientation to domain 2. MD simulations of the MalF-P2 – MalE complex show a highly dynamic interaction of MalF-P2 to the MalE interface. From NMR CPMG kinetic studies, a peculiar kink of alpha-helix alpha2 can be seen introduced upon association. The transition time of this conformational change of the alpha-helix is on the ms timescale, which is matching the exchange rate of the complex formation.

Orientador: Cláudio Cabello / Banca: Fernando Broetto / Banca: Magali Leonel / Banca: Ana Paula Cerino Coutinho / Banca: Mariana Schimidt Rechsteiner / Resumo: Os produtos das hidrólises de amido são glicose, maltose e uma série de oligossacarídeos e polissacarídeos que encontram utilização principalmente na indústria de alimentos. Neste grupo enquadram-se os adoçantes que aditam sabores a produtos que são demandados por consumidores específicos. Atualmente o açúcar mais utilizado no Brasil é a sacarose, produto extraído da cana-de-açúcar, e o mais utilizado mundialmente é a frutose obtida a partir da hidrólise do milho e posterior isomerização da glicose para frutose. A frutose apresenta capacidade edulcorante 30% maior que a sacarose, 2,5 vezes maior que a glicose e 2 vezes mais solúvel que a glicose, com isso, pode ser utilizada em menor quantidade, diminuindo o poder calórico do alimento e viabilizando sua utilização no tratamento da obesidade. Levando em consideração a importância dos adoçantes para o mercado de alimentos, o presente trabalho teve como objetivo realizar estudos sobre o processo de obtenção da frutose a partir de amido de mandioca. Para a execução dos ensaios utilizou-se fontes comerciais de α- amilase e amiloglucosidase, Liquozyme Supra 2.2X e Saczyme 750 AGUg-1, respectivamente, aplicadas em substrato de amido de mandioca em reator agitado com temperatura controlada. Após o processo de hidrólise enzimática, o hidrolisado passou por um processo de purificação utilizando terra diatomácea e carvão ativado em quatro temperaturas (30, 40, 50 e 60°C), com a finalidade de remoção de contaminantes originários da matéria prima, que levam a odor, cor e sabores indesejáveis. Após o tratamento com carvão ativo e terra diatomácea foram realizados ensaios para estabelecer os melhores parâmetros para a realização do processo de isomerização, buscando a conversão de parte da glicose à frutose, utilizando a enzima... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: The products of starch hydrolyses are glucose, maltose and a series of oligosaccharides and polysaccharides which have their main utilization in food industry. This group comprises sweeteners that add flavor to products demanded by specific consumers. Currently the most used sugar in Brazil is sucrose, a product extracted from sugarcane, while the most used sugar worldwide is fructose obtained from maize hydrolysis and subsequent glucose isomerization to fructose. The sweetening capacity of fructose is 30% higher than that of sucrose and 2.5-fold higher than that of glucose; in addition, fructose is 2-fold more soluble than glucose and thus can be used in smaller quantities, decreasing the food's caloric potential and making its use viable in obesity treatment. Considering the importance of sweeteners for the food market, the present study aimed to investigate the process of fructose production from cassava starch. The assays were performed by using commercial sources of α-amylase and amyloglucosidase, Liquozyme Supra 2.2X and Saczyme 750 AGUg-1, respectively, applied to cassava starch substrate in an agitated reactor at controlled temperature. Following the process of enzymatic hydrolysis, the hydrolysate underwent a purification process using diatomaceous earth and activated charcoal at four temperatures (30, 40, 50 and 60°C), in order to remove contaminants originated from the raw material, which lead to undesirable smell, color and flavor. After the treatment with activated charcoal and diatomaceous earth, assays were carried out to establish the best parameters for the isomerization process, aiming at the conversion of part of glucose into fructose, using the enzyme isomerase. The process selected for the studies was in a continuous system where the glucose syrup, previously purified, was continuously pumped... (Complete abstract click electronic access below) / Doutor

Chapter 1gives a general introduction to the CXXC motif found in natural proteins. It then reviews the studies where disulphides were engineered in various proteins. The various strategies developed to engineer metal binding activity and redox activity are described. The objectives behind engineering the CXXC motif into a protein, such as imparting it novel metal-binding and redox activities, are discussed next. Alternative strategies which achieve the same objectives are described as well. This chapter then introduces the model proteins used in the course of this thesis: maltose-binding protein (MBP) and E. coli. Thioredoxin (Trx). This chapter also briefly discusses the role of signal peptide in protein export. Chapter 2describes the experimental studies and their results in which we introduced the widely occurring cysteine motif CXXC into the maltose binding protein (one-at-a-time, in five alpha-helices, at the N-termini) to test three hypotheses: 1) Does a disulphide bond form at the N-terminus? 2) Does the protein acquire any oxido-reductase activity? 3) Does it acquire new metal-binding properties? The results confirmed: 1) Each cysteine pair forms a stable intrahelical disulphide bond under non-reducing conditions. 2) The five mutant proteins acquire considerable oxidoreductase activity, tested by the insulin aggregation assay. 3) The mutants acquire novel metal-binding properties for Ni2+, Cd2+, and Zn2+ upon reduction. Further, introducing the CXXC motif neither destabilizes the protein nor affects its global structure. Our results demonstrated that introduction of CXXC motifs can be used to probe alpha-helix start sites and to introduce oxidoreductase and metal binding functionality into proteins. Chapter 3describes further experimentson a few of the metal ion binding mutants discussed in the previous chapter. We explore the effect and usefulness of reducing agents (DTT and TCEP) on the binding of metal salts to the CXXC mutants. We also studied the explore of metal salts on the thermal stability of the mutants and show that metal ions bind to the CXXC motif even when the protein is in the unfolded state. The chapter describes the use of an immobilized metal affinity chromatography (IMAC) based method for the purification of MBP mutants.Yields ranging from 60-85% were obtained for thethree MBP mutants. The cysteines were located at different positions in thesethree MBP mutants (MBP 42-45 Cys, MBP 128-131 Cys, and MBP 359-359 Cys mutants). The yields for wild-type MBP, a single cysteine mutant (MBP S211C), a double cysteine mutant (MBP 230, 30) were all below 15%. Chapter 3 also reports a new crystal structure of the MBP356-359 mutant in ligand bound form:it crystallizes as an intermolecular dimer, bonded by two disulfides formed by the cysteines of the CXXC motif. Chapter 4describes the effects of inserting signal peptide sequences on protein folding and expression. We fused the malE and pelB signal sequences at the N-terminus of the model protein thioredoxin and observed that the wild-type and pelB fusion constructs are soluble when expressed, but the malE construct was targeted to inclusion bodies. Nonetheless, it could be refolded in vitro to yield a monomeric product with a secondary structure identical to the wild-type thioredoxin. This chapter also details the thermodynamic stability, aggregation propensity and activity of the purified recombinant proteins in comparison with the wild-type thioredoxin. The presence of the signal sequences reduces the thermodynamic stability and activity of the recombinants and increases their aggregation propensity, with malE having much larger effects than pelB. These studies show that besides acting as address labels, different signal sequences affect protein stability and aggregation differently. Chapter 5describes three different strategies to label a protein at different sites with cysteine-specific fluorophores using MBP as the model. The first strategy exploits the differential accessibility of residues within MBP in its maltose-bound and maltose-free states. The second strategy involves insertion of a 14-amino-acid loop called V3 from the HIV gp120 protein into MBP; anti-V3 antibodies shield the cysteine residue present inside the inserted loop, while we label another cysteine present outside the loop. In the third strategy, we introduce a third cysteine residue onto the background of the MBP mutant already containing a disulphide bridge at the N-terminus of one of its helices (discussed in Chapter 2). We label the third, free cysteine while the cysteines involved in the disulphide bridge remain protected. We observed successful differential labelling using the first strategy and also observed FRET between the fluorophore labels. Similarly, after trying the second strategy we could individually label all the mutants except one. The third strategy based on the triple-cysteine mutant was not successful because the fluorophore we chose (DBM) did not show site specificity and instead labelled all three cysteines. In addition, the triple-cysteine mutant did not even show disulphide-bridge formation.We showed that indeed the V3 loop inserted in MBP binds anti-V3 antibodies and we could individually label all the mutants expect D41C. The third strategy was not successful because unfortunately in the triple cysteine mutant, the fluorophore we chose (DBM) did not show site specificity and labeled all three cysteines. In addition, the disulfide bridge was not found to be present in the triple cysteine mutant. Chapter 6discusses the synthesis, characterization and binding of various maltolipids, (and their corresponding maltose-free controls) to MBP. The maltolipids were synthesised with varying linker lengths and anchor- & head-groups and then used to prepare liposomes and micelles. Although both liposomal and micellar forms could bind to MBP, only the micelles were screened subsequently for their ability to bind to MBP. The binding was assessed using various techniques such as fluorescence spectroscopy, gel filtration and thermal stability assay. We screened the maltolipids and determined how their anchor group, linker length and charge on the head group influences the binding of MBP to micelles formed by these maltolipids.